A Comprehensive Bioinformatic Analysis Identifies a Tumor Suppressor Landscape of the MEG3 lncRNA in Breast Cancer
Author:
Publisher
Springer Science and Business Media LLC
Link
https://link.springer.com/content/pdf/10.1007/s13193-024-01992-0.pdf
Reference53 articles.
1. Wilkinson L, Gathani T (2022) Understanding breast cancer as a global health concern. Br J Radiol 95(1130):20211033. https://doi.org/10.1259/bjr.20211033
2. Grogan Fleege NM, Cobain EF (2022) Breast cancer management in 2021: a primer for the obstetrics and gynecology. Best Pract Res Clin Obstet Gynaecol 82:30–45. https://doi.org/10.1016/j.bpobgyn.2022.02.004
3. Liu Z, Mi M, Li X, Zheng X, Wu G, Zhang L (2019) lncRNA OSTN-AS1 may represent a novel immune-related prognostic marker for triple-negative breast cancer based on integrated analysis of a ceRNA network. Front Genet 10:850. https://doi.org/10.3389/fgene.2019.00850
4. Sideris N, Dama P, Bayraktar S, Stiff T, Castellano L (2022) LncRNAs in breast cancer: a link to future approaches. Cancer Gene Ther 29(12):1866–1877. https://doi.org/10.1038/s41417-022-00487-w
5. Sanchez Calle A, Kawamura Y, Yamamoto Y, Takeshita F, Ochiya T (2018) Emerging roles of long non-coding RNA in cancer. Cancer Sci 109(7):2093–2100. https://doi.org/10.1111/cas.13642
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3